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Proteolytic activity develops in human plasma  treated with streptokinase 
(1), urokinase (2, 3), tissue particles or extracts (4,  5) or chloroform (6). The 
protease which evolves in each case has been referred to by the generic name, 
plasmin,  and  seems  to  be  derived  from  the  same  proenzyme, plasminogen 
(7-10). The activation of plasminogen by streptokinase, urokinase and tissue 
extracts may be significantly inhibited by epsilon aminocaproic acid (11,  12). 
The effect of this substance upon the activation of plasminogen by chloroform 
has not been reported. 
The present study is concerned with the effect of epsilon aminocaproic acid 
upon the development of proteolytic activity in chloroform-treated euglobulin 
fractions of human plasma. Epsilon aminocaproic acid not only failed to impede 
but actually enhanced  the development of proteolytic activity, as  measured 
upon a substrate of casein. Although fibrinolytic activity was also enhanced, this 
could be demonstrated only if the chloroform-treated euglobulin was first freed 
of epsilon aminocaproic acid by dialysis. The techniques described, then, permit 
the preparation of plasmin of high proteolytic activity, yet readily separated 
from  the  activating  agents.  The  implications  of  these  observations  will  be 
discussed;  our  studies  have  not  provided  an  adequate  explanation  for  this 
unexpected effect of epsilon aminocaproic acid. 
Nomenclature,  Materials and Methods 
Pl~min (or fibrinolysin) designates the one or several enzymes  of plasma which can digest 
fibrinogen, fibrin, casein and certain other proteins at or near neutrality. It exists in plasma 
in the form of an inactive precursor,  plasminogen (or profibrinolysin).  Plasminogen can be acti- 
vated by streptokinase (a principle found in filtrates of cultures of certain beta hemolytic 
streptococci) (1), uroldnase (a substance found in normal urine) (2, 3), tissue particles (4, 5) 
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and certain organic solvents, notably chloroform (6).  Apparently spontaneous activation of 
plasminogen may also be observed in vitro. Whether plasma contains an activator separable 
from plasminogen is disputed. 
Epsilon  aminocaproic  acid  (6-aminohexanoic  acid)  (Mann  Research  Laboratories,  New 
York) was prepared in distilled water at 10 times the concentrations used in the experiments 
described, permitting the dilution of euglobulins or substrate by only 10 percent in obtaining 
the  desired  concentration. 
Casein  (Hammersten  quality, Nutritional  Biochemicals Corp.,  Cleveland) was prepared 
in a 5 percent solution by the method of Norman (13)  and then dialyzed against the buffer 
used in the test system for 18 hours at 4°C. Epsilon aminoeaproic acid in a final concentration 
of  0.1  ~s  was  included  in  casein  preparations  incubated  with  eugiobulins containing  this 
material, except as noted. In mixtures testing activation in the absence of epsilon aminoca- 
proic acid, buffer was added to casein in its place. 
Streptokinase  t  (high purity, Lederle, Laboratories, Pearl River, New York)  was dissolved 
in imidazole buffer at pH 7.4 in a  concentration of 1000 Christensen units per ml. 
Plasma and serum used as sources of eugiobulins were obtained from the blood of normal 
adults, and had been stored at  -20°C for as long as one month prior to use. 
Commercial  lyophilized bovine fibrinogat  (bovine  fibrinogen,  Warner  Chilcott,  Morris 
Plains, N. J.) was dissolved in water to make a solution containing 3.0 mgm per ml in 0.15 
sodium chloride. Bovine thrombin  (topical thrombin,  Parke  Davis  Co., Detroit)  was dis- 
solved in buffer in a concentration of 10 National Institutes of Health units per ml. 
Bu.ffcrs used to dissolve euglobulin precipitates were: sodium phosphate  (14), tris (2-amino- 
2-hydroxymethyl-1, 3 propanediol)  (Matheson  Co., Norwood, Ohio), or imidazole (Eastman 
Kodak Co., Distillation Products Division, Rochester, New York) adjusted to the pH appro- 
priate for the experiment. The concentration of each was 0.15 ,x. 
Viscose no-jax casings (The Visking Corp., Chicago) were used as dialysis membranes. 
Determinations of pH were made at the beginning and  end of chloroform activation, and 
appropriate adjustments made each time, using a Radiometer pH meter (Radiometer,  Copen- 
hagen,  Denmark).  At the end of an incubation period testing casein hydrolysis, the pH of 
the  incubation  mixture  was  again  tested.  Optical densities  of colorimetric reactions were 
measured in a Beckman model DU spectrophotometer. 
Glassware had been cleaned with dural H  (Wyandotte Chemicals, Wyandotte, Mich.) and 
thoroughly rinsed with tap water and then distilled water. Mixtures undergoing casein diges- 
tion were incubated in Pyrex test tubes having an internal diameter of 11 mm.; those under- 
going fibrinolysis were incubated in Pyrex test tubes having an internal diameter of 8 ram. 
Activation and assay mixtures were tightly stoppered throughout. 
A euglobulinfraaion was prepared by diluting normal human serum or citrated plasma with 
19 volumes of water and adjusting the pH to 5.2 with 1 percent acetic acid (10). The euglob- 
ulin precipitate was separated  by centrifugation at room temperature for 15 minutes at 1500 
mm in an International centrifuge, size 2. This precipitate was redissolved in imidazole, tris, 
or phosphate buffer in a volume one-fourth that of the original plasma or serum. 
Chloroform activation of plasminogen  in euglobulin fractions was performed by a technique 
previously shown to provide optimal conditions for reproducible activation (15). Aliquots of 
0.5 ml of euglobulin solution were mixed with 0.05 ml of either epsilon aminocaproic acid or 
buffer in 40 ml round bottom pyrex centrifuge tubes. Then, 0.5 ml of chloroform was added to 
each, the tubes tightly stoppered,  shaken,  and incubated  at room temperature for 17 to 20 
hours. The supernatant  fluids were separated by centrifugation and tested for casein hydro- 
lyric and fibrinolytic activities. 
x Streptokinase was generously provided by Dr. Virgil Place, Lederle Laboratories,  Pearl 
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Casein hydrolysis by chloroform-activated eugiobulin solutions was measured by a modifi- 
cation of the method of Remmert and Cohen (16). Aliquots of 0.4 ml of eugiobulins,  0.25 ml 
of buffer, and 1.9 ml of casein were incubated together at 37°C for 4 hours, and reactions then 
stopped by adding an equal volume of 0.3 N trichloracetic acid. Control experiments were 
performed in which eugiobulin  mixtures and casein substrate were incubated separately and 
combined just prior to termination of the reaction. The amount of hydrolysis which occurred 
in this time was determined by measuring the trichloracetic  acid-soluble tyrosine-like  material 
by a minor modification of the method of Folin and Ciocalteu  (17). 
To measure flbrinolytic activity, 0.2 ml of euglobulins,  or buffer, 0.4 ml of fibrinogen and 
0.1 ml of bovine thrombin were mixed at 4°C and then incubated at 37°C. The time from the 
addition of thrombin to complete lysis of the fibrin which formed was recorded as the clot 
lysis time. 
TABLE I 
Effect of Epsilon A minocaproic Acid (EA CA  ) on Activation of Proteolysis in 
Euglobulins Treated with Chloroform 
Casein Hydrolysis:  Fibrinolysis: clot 
Activation Mixture  acid-soluble tyrosine-like  lysis times 
materials liberated 
pg  hrs. 
69  Chloroform-euglobulins  with 0.1 u  EACA 
Chloroform-euglobulins  with buffer 
Buffer control 
36 
32 hrs. 
5 hrs. 
No lysis in 32 hrs. 
Euglobulin fractions prepared as described were mixed either with buffer or with sufficient 
EACA to give a concentration of 0.1 M  in the activation mixture and then treated with chloro- 
form. The supernatant fluids were tested for casein hydrolytic  and fibrinolytic  activity. Casein 
digestion is expressed as micrograms of acid-soluble tyrosine-like materials per rnillillter of 
digestion mixture; fibrin digestion as the time required for complete lysis of the clotted mix- 
ture, During activation and assay, pH was maintained at 7.4 4- 1. 
EXPEl~ T~~.NTAL 
1.  Effect  of Epsilon Aminocaproic  Acid on  Chloroform  Activation  of Casein 
and  Fibrin Hydrolytic Properties  in Euglobulins.--Chloroform-activated  plas- 
minogen  in  euglobulin preparations  digested casein readily  (Table  I).  Com- 
parable euglobulins which  contained  0.1  ~  epsilon aminocaproic acid during 
chloroform activation usually digested casein even more rapidly. This enhanced 
activity was observed even when both the activation and assay mixtures con- 
tained 0.1 M epsilon aminocaproic acid. This is in sharp contrast to the effect 
of  epsilon  aminocaproic  acid  upon  streptokinase  (11,  12)  or  urokinase  (12) 
activation of plasminogen; casein hydrolysis is diminished in  these  instances. 
Other  experiments  tested  the  effect  of  0.1  M  epsilon  aminocaproic  acid  on 
euglobulins which had already been activated with chloroform in its absence. 
These euglobulins frequently, but not always, digested less casein than  those 
which contained epsilon aminocaproic acid during activation. 698 
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FIo.  1. Effect of epsilon aminocaproic acid  (EACA)  on casein hydrolysis and fibrinolysis 
by chloroform-treated euglobulins at variable hydrogen ion concentrations. Euglobulin frac- 
tions of plasma whose pH had been appropriately adjusted, were mixed with EACA, to pro- 
vide 0.1  ~  concentration, or with buffer.  Following activation with chloroform, they were 
tested for fibrinolytic and casein hydrolytic activities. In this experiment, casein and fibrin 
substrates did not contain added EACA. pH levels were maintained during activation and 
subsequent  assay.  Casein  hydrolysis  is  expressed  as  acid-soluble  tyrosine-like  materials 
liberated in rmcrograms per milliliter of digestion mixture. Fibrin digestion is expressed as time 
required for complete lysis of the clotted mixture. Clots in the fibrinolytic assay containing 
EACA in the euglobulins were not observed between 7 and 14 hours. 
On the contrary, fibrin digestion was markedly inhibited when 0.1 ~  epsilon 
aminocaproic acid was present during activation and assay (Table I). Even in 
the absence of epsilon aminocaproic acid, fibrin digestion by chloroform acti- 
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2. Effect of Varied Hydrogen Ion Concentration.--Euglobulins  in 0.1 ~t epsilon 
aminocaproic acid or phosphate buffer were treated with chloroform after the 
pH  of the  solutions  had  been  adjusted  to various  levels.  Assays for casein 
hydrolysis by these euglobulins  were performed at  the pH corresponding  to 
that  of activation.  Maximal  casein  hydrolysis occurred between pH  7.0 and 
8.0 (Fig.  1), as has been previously shown for both streptokinase- and chloro- 
form-activated euglobulins  (8,  10). When euglobulins  in 0.1 M epsilon  amino- 
caproic acid were tested,  casein digestion  was enhanced  at  each  pH  tested; 
the decrease in casein  hydrolysis at pH 7.5 noted in Fig.  1 was inconsistent. 
Fibrin digestion by euglobulins  in buffer was also most rapid between pH 7.0 
and  8.0.  Again,  the  presence  of  epsilon  aminocaproic  acid  during  activa- 
tion and assay markedly inhibited fibrinolysis  (Fig.  1). In these experiments, 
the final concentration of epsilon aminocaproic acid in assays for casein hydroly- 
sis was 0.016 •  and in fibrinolytic assays, 0.028 ~t. Either concentration has been 
reported  to inhibit  the activation  of plasminogen  by streptokinase in a  con- 
centration of 50 units per ml.  (12). 
3. Effect of Concentration and Ionic Strength.--I.n  human serum, the produc- 
tion of fibrinolytic activity by streptokinase is inhibited by increasing  the ionic 
strength  of the  activation  mixture  (18).  The  fibrinolytic  activity of bovine 
plasmin,  however, is enhanced by increasing  the ionic strength of the reaction 
mixture  (18).  Euglobulins  dissolved in  hypertonic  sodium  chloride  digested 
less  casein  after  chloroform activation  than  those in  a  more nearly  isotonic 
solution  (Table II).  Similarly,  euglobulins  containing  a  higher  concentration 
TABLE  II 
Effect of Salt and Epsilon Aminocaproic Acid (EA  CA ) Concentration on Activation of 
Proteolysis in Cldoroform-Treated Eugtobulins 
Activation mixture 
Chloroform +  euglobulins in 0.4 ~  EACA 
Chloroform +  euglobulins in 0.1 ~s EACA 
Chloroform +  euglobulJns in 0.4 ~s NaC1 
Chloroform +  euglobulins in 0.1 M NaC1 
Casein hydrolysis: 
acid-soluble 
tyrosine-like 
materials liberated 
/~g 
32 
56 
20 
34 
Fibfinolysls: 
clot lysis times 
]'~r$. 
14 hrs. 
6 hrs. 
14 hrs. 
3s~ hrs. 
In  this experiment, EACA  or NaCI was  added  to plasma euglobulins to provide con- 
centrations nbted. Following activation with chloroform the digestion of casein and of fibrin 
by these euglobulins was  measured.  Casein hydrolysis is expressed as micrograms of acid- 
soluble tyrosine-like materials per milliliter of digestion mixture. The pH of  these mixtures 
was maintained at 7.4--7.5 during activation and assay. 7OO  ENHANCED  PLASMA  PROTEOLYTIC  ACTIVITY 
of  epsilon  aminocaproic  acid  developed  less  activity  than  those  containing 
less  (Table  II);  indeed,  the  greatest  amount  of  casein  hydrolytic  activity 
evolved when 0.1  M epsilon aminocaproic acid was present during chloroform 
activation as  compared to  other  concentrations  ranging  from 0.4  M to 0.001 
M.  However, euglobulins  containing  epsilon aminocaproic acid  during  activa- 
tion  digested  casein  more  readily  than  those  in  the  same  concentration  of 
sodium  chloride.  Moreover,  the  addition  of  epsilon  aminocaproic  acid  to 
euglobulins  already  containing  a  high  concentration  of  sodium  chloride 
increased casein hydrolysis following chloroform treatment (Table III). These 
experiments indicate that the effect of epsilon aminocaproic acid on chloroform 
activation differs from that of increased ionic strength. 
TABLE III 
Effect of Epsilon Aminocaproic Acid (EACA) and Increased Ionic Strength on Chloroform 
Activation of Euglolmlins 
Activation  mixture 
Chloroform with euglobulins in 0.1 M EACA and 0.4 
NaC1 
Chloroform with euglobulins in 0.4 ~ NaC1 
Casein hydrolysis: 
acid-soluble 
tyrosine-like 
materials liberated 
#g 
30 
15 
Fibrinolysis: 
clot  lysis  times 
h~s. 
22 
22 
Activation and assays were performed just as in  the  previous experiment (Table II), 
using EACA in hypertonic saline, or hypertonic saline alone as additives to activation mix- 
tures. Casein digestion is expressed as micrograms of acid-soluble tyrosine-like materials per 
milliliter of digestion mixture. The pH of both activation and assay mixtures was maintained 
at 7.35-7.5 throughout. Clots were not observed between 11 and 22 hours. 
4.  Heat  Stability  of Precursors  of Chloroform-Induced  Enzymatic  Properties 
in Serum.--Plasminogen is said  to be stable at  56°C  but  inactivated at  62°C 
within  30  minutes  (15,  19).  Euglobulin  solutions  were prepared from serum  2 
which had been heated to 56°C or 65°C, or kept at 4°C for 30 minutes. These 
three  euglobulin solutions  were then  treated  with chloroform in  the presence 
of either 0.1  ~r epsilon aminocaproic acid or buffer, and tested for their ability 
to digest casein and fibrin. 
Euglobulins  derived from 56°C  heated serum demonstrated  approximately 
the same degree of casein hydrolysis as those prepared from 4°C treated serum 
(Table IV).  Epsilon aminocaproic acid  enhanced  casein hydrolysis and  again 
inhibited  fibrinolysis.  Heating serum  to  65°C  resulted  in  loss  of chloroform- 
2  Serum was used in this experiment because of the precipitation of fibrinogen and other 
proteins which occurs when plasma is incubated at the higher temperature. VIRGINIA  H.  DONALDSON  AND  OSCAR D.  RATNOFF 
TABLE IV 
Properties of Chloroform-Treated Euglobulins Derived From 56°C Heated Serum 
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Sample 
56°C chloroform-euglobulins  with 0.1 ~ EACA 
56°C chloroform-euglobulins  with buffer 
4°C chloroform-euglobulins  with 0.1 ~ EACA 
4°C chloroform-euglobulins  with buffer 
Casein hydrolysis: 
acid-soluble 
tyrosine-like 
materials liberated 
62 
12 
28 
16 
Fibrinolysis: 
clot lysis times 
h~$. 
25 hrs. 
6 hrs. 
25 hrs. 
10 hrs. 
Euglobulins were prepared from serum which had first been incubated at 56°C for 30 
minutes, and from some of the same serum which had been at 4°C during this incubation 
period. Then, the effect of epsilon aminocaproic acid (EACA) upon chloroform activation 
was tested.  Hydrolysis of casein is expressed as micrograms of acid-soluble tyrosine per 
milliliter of digestion mixture. Time for complete lysis  of clots denotes fibrinolytic activity. 
Clots were not observed between 14 and 25 hours. During both activation and assay, pH was 
maintained at 7.4-7.5. 
induced casein hydrolysis even though epsilon aminocaproic acid was  present 
during activation. Fibrinolytic potential was also lost. Therefore, the protease 
which  appeared  in  serum  euglobulins  treated  with  chloroform  and  epsilon 
aminocaproic acid was derived from a  precursor with the same  heat stability 
as plasminogen. 
5. Effect of Epsilon Aminocaproic Acid Alone on Plasma Euglobulins.--These 
experiments raised the question  of whether proteolytic activity would evolve 
in euglobulins treated with epsilon aminocaproic acid in the absence of chloro- 
form. Euglobulins prepared as described, and incubated  at room temperature 
for  18  hours with either 0.1  ~t  epsilon aminocaproic  acid  or  buffer  digested 
negligible amounts of fibrin and casein. 
Epsilon aminocaproic acid was not soluble in chloroform, nor did incubation 
with chloroform alter its ability to inhibit streptokinase activation. Its failure 
to inhibit production of casein hydrolytic properties in a chloroform-euglobulin 
mixture, then, could not be attributed to its unavailability in this mixture. 
6.  Properties  of Chloroform-Treated  Euglobulins following Dialysis to Remove 
Epsilon  Aminocaproic  Acid.--In  the  experiments  described  in  the  previous 
sections  epsilon aminocaproic acid  prevented neither  the  appearance nor  the 
measurement of casein hydrolytic activity in  chloroform-treated euglobulins, 
whereas virtually no fibrinolytic activity was found. The question  then arose 
as  to  whether  the  presence  of  epsilon  aminocaproic  acid  in  assays  for  the 702  ENHANCED PLASMA PROTEOLYTIC ACTIVITY 
digestion  of casein  and  fibrin  may have  interfered  with  the  measurement  of 
these activities. 
Plasma  euglobulins  were  dissolved  in  buffered  0.1  M epsilon  aminocaproic 
acid,  or buffer alone,  and  then  treated  with  chloroform. At  the  end  of an  18 
hour  activation  period,  chloroform  was  removed  and  the  euglobulins  tested 
for casein hydrolytic and fibrinolytic activity, using substrates  containing 0.1 
M epsilon  aminocaproic acid or buffer.  As in previous experiments,  the  euglob- 
ulins  containing  epsilon  aminocaproic  acid  had  a  large  amount  of  casein 
TABLE V 
Casein  and  Fibrin  Digestion  by  Chloroform-Treated  Euglobulins  with  and  Without  Epsilon 
Aminocaproic Acid (EACA ): Effect of Dialysis on these Activities 
Chloroform-euglobulins 
~tarting sample  with 0.1  ~r EACA 
~ssay system.. 
Prior to dialysis 
~fter dialysis 
~fter  dialysis  +  50  units 
S-K 
Casein  Fibrinolysis: 
hydrol-  clot lysis 
ysls*  times 
66  32 hrs. 
106  13 min. 
250  3 min. 
Chloroform-euglobulins 
with buffer 
Casein 
hydrol, 
ysis* 
34 
36 
108 
Fibrinolysis: 
clot  lysis 
times 
4 hrs. 
65 min. 
5 min. 
Untreated euglobulins 
+  50 units S-K 
Casein 
hydrol- 
ysis* 
114 
Fibrinolysls: 
clot  lysis 
times 
10 min. 
* Expressed as acid-soluble tyrosine-like materials  liberated  in micrograms per milliliter 
of digestion mixture. 
Euglobulins were prepared from normal plasma, and divided into 3 samples. One of these 
was treated with chloroform after addition of EACA to give 0.1 x~ concentration, one treated 
with chloroform after addition  of buffer instead of EACA, and the other tested for strepto- 
kinase  (S-K) activatable  materials  without  prior  chloroform treatment.  The  chloroform- 
treated euglobulins were then dialyzed against  cold water  to remove dialyzable inhibitors. 
They were then retested for casein and fibrin hydrolytic activities in the presence and absence 
of 50 units of S-K. 
hydrolytic activity but almost no fibrinolytic activity, while less casein hydrol- 
ysis  and  more  fibrinolysis  was  produced  by  euglobulins  containing  buffer. 
Mter  these  assays,  the  remainder  of  each  sample  was  dialyzed  against  cold 
running tap water for a  period of 15 hours,  and retested  (Table  V). Following 
dialysis,  samples  which had been  treated  with  chloroform and epsilon  amino- 
caproic acid had even more casein hydrolytic activity, and striking fibrinolytic 
activity.  In contrast,  those  treated  with  chloroform and buffer demonstrated 
no increase in their ability to digest casein and a less striking increase in fibrino- 
lyric activity. Moreover, after dialysis, the addition of streptokinase evoked an 
even greater amount of casein digestion in those samples originally containing 
epsilon aminocaproic acid than in those mixed with buffer prior to activation. 
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epsilon  aminocaproic acid,  and the subsequent removal of  this material by 
dialysis then, is a way of preparing an active fibrinolytic preparation of human 
origin free of streptokinase. Although we did not determine by chemical means 
the amount of epsilon aminocaproic acid remaining in the euglobulin fraction 
after dialysis,  the increase in fibrin  and casein hydrolysis with and without 
streptokinase suggested that it had been effectively  removed (20). 
DISCUSSION 
The  development  of  proteolytic  activity in  mixtures  of  chloroform and 
plasma euglobulins was enhanced when epsilon aminocaproic acid was present. 
Epsilon aminocaproic acid in the same concentration inhibits the production 
of proteolytic activities in human plasma by streptokinase, urokinase, or tissue 
extracts  (11, 12). The  proteolytic  activity which  appeared  in  chloroform- 
treated euglobulins  could be demonstrated upon a  substrate of casein  even 
though the epsilon aminocaproic acid was not removed prior to assay. Fibrino- 
lyric activity, however, could be detected only if the epsilon  aminocaproic 
acid was first removed by dialysis. 
The proteolytic activity which appears  in  euglobulin  fractions of human 
plasma,  treated with chloroform or with streptokinase, has been attributed 
to  the  activation  of  the  proenzyme, plasminogen  (7-10).  The  mechanism 
underlying these activations of plasminogen  is unclear. Chloroform is said to 
diminish the inhibitory activity of human plasma against plasmin; this has 
led to  the suggestion  that  chloroform promotes plasmin formation by pro- 
viding conditions  favorable for autocatalysis (9).  This explanation is perhaps 
inadequate, since purified preparations of plasminogen have not been observed 
to autoactivate except in high concentrations of glycerol (21).  Similarly,  the 
activation of plasminogen by str,  eptokinase is only dimly understood. Originally 
thought to be a  catalytic agent (8, 9)  streptokinase apparently undergoes a 
preliminary stoichiometric reaction with an unidentified component of plasma, 
and the complex which results is thought to induce typical plasmin-like activity 
(15). The nature of the component with which streptokinase reacts is disputed 
(22), but it has not yet been possible  to separate it from plasminogen  itself 
(15, 23). 
The present experiments provide no explanation for the paradoxical behavior 
of epsilon  aminocaproic acid.  Casein hydrolytic activity developed optimally 
in 0.1 M epsilon aminocaproic acid, an amount not only sufficient to inhibit the 
activation of plasminogen  by streptokinase, but in addition the proteolytic 
activity of glycerol or streptokinase-activated plasmin,  or trypsin  (12).  We 
have been unable to show that epsilon aminocaproic acid, which has a terminal 
primary amino group, enhances the effect of chloroform by additional destruc- 
tion of plasmin inhibitors,  as has been observed with non-polar primary amines 
(24, 25). One attractive, but unproved, hypothesis is that epsilon aminocaproic 704  ENHANCED  PLASMA  PROTEOLYTIC  ACTIVITY 
acid protects plasmin from autodigestion, permitting the accumulation of this 
enzyme during its protracted  incubation with chloroform. Others  have sug- 
gested that glycerol, urea, and methylamine have such a protective effect upon 
plasminogen prepared by the method of Kline (21, 26). 
Once  activated,  the  plasmin-like  activity--which  evolved  in  chloroform- 
treated  euglobulins in  the  presence  of  epsilon  aminocaproic  acid--digested 
casein, but not fibrin, unless the epsilon aminocaproic acid was first removed 
by dialysis. There are several possible explanations for this. Perhaps the activity 
attributed to plasmin is due to several enzymes. Thus, more than one enzyme 
may  have  been  activated  by  chloroform  treatment  of  euglobulins.  Then, 
increased casein digestion in the absence of fibrin digestion may have been due 
to an enzyme which is not fibrinolytic. If both substrates are digested by a single 
enzyme derived from plasminogen, different sites of such a  molecule may be 
involved in casein and fibrin digestion. Another possibility is that there may 
be more  than one active enzyme molecule derived from a  single proenzyme, 
plasminogen. 
A  more likely explanation for the difference between its behavior  toward 
casein and its behavior toward fibrin is in the mechanisms by which the treated 
euglobulin may digest the two substrates. Perhaps casein is attacked directly 
while fibrin is digested only after the euglobulin reacts with some component 
of the thrombin or fibrinogen preparations used  to form the clot.  It is  well 
known that bovine fibrinogen preparations are contaminated with a plasmino- 
gen-like substance.  Our  experiments  suggest that  epsilon aminocaproic  acid 
inhibits the reaction between chloroform-treated euglobulins and this "plasmi- 
nogen" in the clot used for assay. 
If the fibrinogen itself were altered by epsilon aminocaproic acid, this could 
explain these observations. We have found that fibrin formation may actually 
be accelerated, rather than delayed by 0.1 ~  epsilon aminocaproic acid (25). 
Austen extensively studied esterase activities induced in human serum by 
chloroform, peptone, and antigen-antibody complexes and found chloroform- 
induced esterases  to  be  unassociated with casein hydrolytic properties  (26). 
These activities further differed  from those in the present report in that euglob- 
ulin fractions or serum first heated to 56°C  and then treated with chloroform 
did not become esterolytic (26). Perhaps the discrepancies in these observations 
may be  ascribed  to  differences in  technique  of  chloroform  treatment.  The 
method which we have used provides maximal casein hydrolytic properties in 
euglobulins which have been incubated with chloroform at 25°C for 16 to 28 
hours,  but  none  if incubation  is  carried  out  at  4°C  (15).  Austen's  method 
employs a brief exposure of serum to chloroform, and separation of the super- 
natant fluids which are then incubated at 4°C. Maximal esterase activity did 
not appear until 4 days had elapsed, and was stable for a  protracted period 
(26).  We have not compared the esterolytic properties which may be induced 
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Our experiments have confirmed earlier reports of some of the characteristics 
of plasmin  derived from crude euglobulin fractions  of human plasma.  Plasmi- 
nogen has been shown to resist heating  at 56°C but not 65°C for 30 minutes 
(15, 19); the heat lability of the proenzyme activated in the presence of epsilon 
aminocaproic  acid was similar  (Table IV).  The  optimal pH for the digestion 
of  casein  and  fibrin  by chloroform-treated  euglobulins  is  in  agreement  with 
previous findings  (8,  10); epsilon aminocaproic  acid did not alter  the optimal 
pH  for  casein hydrolysis  significantly,  but  as has  been mentioned,  inhibited 
fibrinolysis.  Similarly  it  has  been  shown  previously  that  the  induction  of 
fibrinolytic  activity  by  streptokinase  was  inhibited  by  increasing  the  ionic 
strength  of the activation mixture  (18); in the present  experiments  increasing 
the ionic strength  inhibited  the activation  of plasminogen by chloroform. 
Finally,  the  techniques  described provide a  ready way of preparing  active 
preparations  of plasmin free of extrinsic activators,  since both chloroform and 
epsilon  aminocaproic  acid  may be  removed  readily. 
SDM~/d~¥ 
The proteolytic activity in chloroform-treated  plasma euglobulins has been 
attributed  to  plasmin.  Plasmin  can  digest  both  casein  and  fibrin.  Epsilon 
aminocaproic acid, which inhibits  the activation of plasminogen,  the precursor 
of plasmin,  by streptokinase,  urokinase,  and  tissue  activators  enhanced  the 
development  of  casein  hydrolytic  activity  in  a  mixture  of  chloroform  and 
plasma  euglobulins.  Fibrinolytic  activity  was  also  enhanced,  but  this  was 
evident only if the epsilon aminocaproic acid was removed from the chloroform- 
treated  euglobulins  prior  to assay.  The  reasons  for  the paradoxical  enhance- 
ment of chloroform-induced casein hydrolysis by euglobulins containing epsilon 
aminocaproic acid are unclear.  However, studies of optimal pH, heat stability, 
and  the  effect  of  ionic  strength  on  the  activation  of  the  precursor  of  this 
proteolytic enzyme do not differentiate  it  from plasminogen. 
The authors are indebted to Dr. Irvine H. Page for his helpful criticisms of this manuscript, 
and to Mr. William Bennett for his technical assistance. 
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